A retrospective cohort analysis comparing the effectiveness and safety of perioperative angiotensin II to adrenergic vasopressors as a first-line vasopressor in kidney transplant recipients

Table 4 Safety Outcomes

Variable	AT2S (n=20)	Adrenergic Vasopressors (n=60)	p-value
Intra- or postoperative arrhythmia, n (%)	1 (5)	17 (28.3)	0.03
Digital or other peripheral/visceral ischemia, n (%)	0	11 (18.3)	0.031
Need for insulin infusion, n (%)	5 (25)	16 (26.7)	0.883
Thrombotic events, n (%)	0 (0)	0 (0)	n/a

AT2S synthetic angiotensin II, eGFR estimated glomerular filtration rate, n/a not applicable, SCr Serum creatinine

ISSN: 2731-3786